Back to search
FDAFDA · Food and drugs·Recall number Z-0355-2027

Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens

Published November 11, 2026 · Recall initiated: October 19, 2026

Summary

FDA records medical device Class II recall Z-0355-2027, published November 11, 2026 and initiated October 19, 2026. Recalling firm: Remel, Inc; Status: Ongoing; Reported quantity: 33 US, 54 OUS; Lot: YY3462 lot 440400 UDI-DI 848838018817. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel, Inc
Distributor
Worldwide - US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK.
Lot
YY3462 lot 440400 UDI-DI 848838018817
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens recalled?

Yes. FDA published recall Z-0355-2027 on November 11, 2026. Reported hazard: Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.

What should I do if I have this product?

Voluntary: Firm initiated · Letter